Ligand to Present at BIO CEO and Investor Conference on February 9
SAN DIEGO-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that President and Chief Executive Officer, John L. Higgins and Vice President of Discovery Research, Dr. Martin Meglasson will both present at the BIO CEO and Investor Conference on Monday, February 9, 2009, at 9:00 a.m. Eastern time (6:00 a.m. Pacific). The conference takes place at the Waldorf-Astoria Hotel in New York City.
A live webcast of the presentation will be available on the Company's website www.ligand.com. A replay of the presentation will be archived on the site for 30 days.
About Ligand Pharmaceuticals
Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory diseases and anemia. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology.
Source: Ligand Pharmaceuticals Incorporated
Released February 3, 2009